88 related articles for article (PubMed ID: 19885927)
1. RBSP3 is frequently altered in premalignant cervical lesions: clinical and prognostic significance.
Mitra S; Mazumder Indra D; Bhattacharya N; Singh RK; Basu PS; Mondal RK; Roy A; Zabarovsky ER; Roychoudhury S; Panda CK
Genes Chromosomes Cancer; 2010 Feb; 49(2):155-70. PubMed ID: 19885927
[TBL] [Abstract][Full Text] [Related]
2. Association of P16-RBSP3 inactivation with phosphorylated RB1 overexpression in basal-parabasal layers of normal cervix unchanged during CACX development.
Chakraborty C; Roychowdhury A; Samadder S; Roy A; Mandal RK; Basu P; Roychoudhury S; Panda CK
Biochem J; 2016 Oct; 473(19):3221-36. PubMed ID: 27458253
[TBL] [Abstract][Full Text] [Related]
3. Alterations of RASSF1A in premalignant cervical lesions: clinical and prognostic significance.
Mitra S; Mazumder Indra D; Basu PS; Mondal RK; Roy A; Roychoudhury S; Panda CK
Mol Carcinog; 2012 Sep; 51(9):723-33. PubMed ID: 21809394
[TBL] [Abstract][Full Text] [Related]
4. Frequent alterations of the candidate genes hMLH1, ITGA9 and RBSP3 in early dysplastic lesions of head and neck: clinical and prognostic significance.
Ghosh A; Ghosh S; Maiti GP; Sabbir MG; Zabarovsky ER; Roy A; Roychoudhury S; Panda CK
Cancer Sci; 2010 Jun; 101(6):1511-20. PubMed ID: 20412120
[TBL] [Abstract][Full Text] [Related]
5. [Tumor suppressor gene RBSP3 in cervical carcinoma: copy number and transcriptional level].
Anedchenko EA; Kiseleva NP; Dmitriev AA; Kiselev FL; Zabarovskiĭ ER; Senchenko VN
Mol Biol (Mosk); 2007; 41(1):86-95. PubMed ID: 17380895
[TBL] [Abstract][Full Text] [Related]
6. [Down-regulation of RBSP3/CTDSPL, NPRL2/G21, RASSF1A, ITGA9, HYAL1 and HYAL2 genes in non-small cell lung cancer].
Anedchenko EA; Dmitriev AA; Krasnov GS; Kondrat'eva TT; Kopantsev EP; Vinogradova TV; Zinov'eva MV; Zborovskaia IB; Polotskiĭ BE; Sakharova OV; Kashuba VI; Zabarovskiĭ ER; Senchenko VN
Mol Biol (Mosk); 2008; 42(6):965-76. PubMed ID: 19140316
[TBL] [Abstract][Full Text] [Related]
7. Frequent alterations of hMLH1 and RBSP3/HYA22 at chromosomal 3p22.3 region in early and late-onset breast carcinoma: clinical and prognostic significance.
Sinha S; Singh RK; Alam N; Roy A; Roychoudhury S; Panda CK
Cancer Sci; 2008 Oct; 99(10):1984-91. PubMed ID: 19016758
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of SLIT2-ROBO1/2 pathway in premalignant lesions of uterine cervix: clinical and prognostic significances.
Mitra S; Mazumder-Indra D; Mondal RK; Basu PS; Roy A; Roychoudhury S; Panda CK
PLoS One; 2012; 7(6):e38342. PubMed ID: 22719878
[TBL] [Abstract][Full Text] [Related]
9. p53 and p21 expression in precancerous lesions and carcinomas of the uterine cervix: overexpression of p53 predicts poor disease outcome.
Huang LW; Chou YY; Chao SL; Chen TJ; Lee TT
Gynecol Oncol; 2001 Nov; 83(2):348-54. PubMed ID: 11606096
[TBL] [Abstract][Full Text] [Related]
10. Analysis of molecular alterations in chromosome 8 associated with the development of uterine cervical carcinoma of Indian patients.
Bhattacharya N; Singh RK; Mondal S; Roy A; Mondal R; Roychowdhury S; Panda CK
Gynecol Oncol; 2004 Nov; 95(2):352-62. PubMed ID: 15491757
[TBL] [Abstract][Full Text] [Related]
11. The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions.
Dimitrakakis C; Kymionis G; Diakomanolis E; Papaspyrou I; Rodolakis A; Arzimanoglou I; Leandros E; Michalas S
Gynecol Oncol; 2000 Apr; 77(1):129-36. PubMed ID: 10739702
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of CHEK1 and EI24 is associated with the development of invasive cervical carcinoma: clinical and prognostic implications.
Mazumder Indra D; Mitra S; Singh RK; Dutta S; Roy A; Mondal RK; Basu PS; Roychoudhury S; Panda CK
Int J Cancer; 2011 Oct; 129(8):1859-71. PubMed ID: 21154811
[TBL] [Abstract][Full Text] [Related]
13. Association of p27Kip1, cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms.
Dellas A; Schultheiss E; Leivas MR; Moch H; Torhorst J
Anticancer Res; 1998; 18(6A):3991-8. PubMed ID: 9891436
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of PTCH1 is associated with the development of cervical carcinoma: clinical and prognostic implication.
Chakraborty C; Dutta S; Mukherjee N; Samadder S; Roychowdhury A; Roy A; Mondal RK; Basu P; Roychoudhury S; Panda CK
Tumour Biol; 2015 Feb; 36(2):1143-54. PubMed ID: 25330948
[TBL] [Abstract][Full Text] [Related]
15. Methylation patterns of Rb1 and Casp-8 promoters and their impact on their expression in bladder cancer.
Malekzadeh K; Sobti RC; Nikbakht M; Shekari M; Hosseini SA; Tamandani DK; Singh SK
Cancer Invest; 2009 Jan; 27(1):70-80. PubMed ID: 19160091
[TBL] [Abstract][Full Text] [Related]
16. High expression of human telomerase reverse transcriptase in high-grade intraepithelial neoplasia and carcinoma of uterine cervix and its correlation with human papillomavirus infection.
Wang PH; Chen GD; Chang H; Yang SF; Han CP; Lin LY; Ko JL
Reprod Sci; 2007 May; 14(4):338-48. PubMed ID: 17644806
[TBL] [Abstract][Full Text] [Related]
17. [Correlations between the HPV type, DNA index and evolution of cervical intraepithelial neoplasia (CIN)].
Sassi I; Mangili F; Luchini S; Colombo G; Pezzotta MG; Candiani M; Frigerio A; Santambrogio G; Cantaboni A; Vignali M
Pathologica; 1993; 85(1095):79-84. PubMed ID: 8390639
[TBL] [Abstract][Full Text] [Related]
18. Alterations of the retinoblastoma gene in human prostate adenocarcinoma.
Tricoli JV; Gumerlock PH; Yao JL; Chi SG; D'Souza SA; Nestok BR; deVere White RW
Genes Chromosomes Cancer; 1996 Feb; 15(2):108-14. PubMed ID: 8834174
[TBL] [Abstract][Full Text] [Related]
19. Alterations of ATM and CADM1 in chromosomal 11q22.3-23.2 region are associated with the development of invasive cervical carcinoma.
Mazumder Indra D; Mitra S; Roy A; Mondal RK; Basu PS; Roychoudhury S; Chakravarty R; Panda CK
Hum Genet; 2011 Dec; 130(6):735-48. PubMed ID: 21643982
[TBL] [Abstract][Full Text] [Related]
20. Microsatellite instability is a late event in the carcinogenesis of uterine cervical cancer.
Nishimura M; Furumoto H; Kato T; Kamada M; Aono T
Gynecol Oncol; 2000 Nov; 79(2):201-6. PubMed ID: 11063644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
